Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Antimicrobial Resistance, Request for Applications (RFA) CI 06-003

---
identifier: "/us/fr/E6-5718"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Antimicrobial Resistance, Request for Applications (RFA) CI 06-003"
title_number: 0
title_name: "Federal Register"
section_number: "E6-5718"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Antimicrobial Resistance, Request for Applications (RFA) CI 06-003"
positive_law: false
currency: "2006-04-18"
last_updated: "2006-04-18"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E6-5718"
document_type: "notice"
publication_date: "2006-04-18"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "71 FR 19890"
fr_volume: 71
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Antimicrobial Resistance, Request for Applications (RFA) CI 06-003

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Antimicrobial Resistance, RFA CI 06-003.

*Time and Date:* 8 a.m.-5 p.m., May 10, 2006 (Closed).

*Place:* Centers for Disease Control and Prevention, 1600 Clifton Road NE., Building 19, Room 231, Auditorium B1, Atlanta, GA 30333.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Antimicrobial Resistance, RFA CI 06-003.

*Contact Person For More Information:* M. Chris Langub, PhD, Scientific Review Administrator, Office of Extramural Programs, NIOSH, CDC, 1600 Clifton Road NE, Mailstop E74, Atlanta, GA 30333, Telephone 404-498-2543. The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: April 12, 2006.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.